Association Between MTHFR Gene Common Variants, Serum Homocysteine, and Risk of Early-Onset Coronary Artery Disease: A Case-Control Study.


Journal

Biochemical genetics
ISSN: 1573-4927
Titre abrégé: Biochem Genet
Pays: United States
ID NLM: 0126611

Informations de publication

Date de publication:
Apr 2020
Historique:
received: 11 04 2019
accepted: 03 09 2019
pubmed: 26 9 2019
medline: 20 11 2020
entrez: 26 9 2019
Statut: ppublish

Résumé

The common variants of the methylenetetrahydrofolate reductase (MTHFR) gene are related to the activity of the MTHFR enzyme and the concentrations of blood homocysteine (Hcy). This study was designed to investigate the associations of MTHFR in Chinese populations with early-onset coronary artery disease (EOCAD). The two common variants of the MTHFR gene were genotyped in 875 EOCAD patients and 956 controls using PCR, followed by direct sequencing of the PCR product. Serum levels of Hcy were measured using an automatic biochemistry analyzer. A significant association between the MTHFR-677C/T variant and the risk of EOCAD was detected in CC versus TT (odds ratio (OR) 1.456, 95% confidence interval (CI) 1.120-1.892), dominant genetic model (OR 1.266, 95% CI 1.027-1.546), and recessive genetic model (OR 1.306, 95% CI 1.040-1.639). Hcy was most abundant in TT genotype (18.31 ± 7.22 μmol/L), least abundant in CC genotype (11.37 ± 5.23 μmol/L), and detectable at intermediate levels in heterozygotes (15.25 ± 6.58 μmol/L). Elevated serum Hcy levels were an independent risk factor for EOCAD (OR

Identifiants

pubmed: 31552564
doi: 10.1007/s10528-019-09937-x
pii: 10.1007/s10528-019-09937-x
doi:

Substances chimiques

Homocysteine 0LVT1QZ0BA
MTHFR protein, human EC 1.5.1.20
Methylenetetrahydrofolate Reductase (NADPH2) EC 1.5.1.20

Types de publication

Journal Article

Langues

eng

Sous-ensembles de citation

IM

Pagination

245-256

Subventions

Organisme : National Natural Science Foundation of China
ID : 81672073
Organisme : China Postdoctoral Science Foundation
ID : 2016M590620

Auteurs

Shao-Yan Zhang (SY)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Chao Xuan (C)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China. bio-x.c@hotmail.com.

Xue-Chun Zhang (XC)

Department of Anesthesiology, Weishan People's Hospital, Jining, China.

Jie Zhu (J)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Kang Yue (K)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Peng Zhao (P)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Guo-Wei He (GW)

Department of Surgery, TEDA International Cardiovascular Hospital, Tianjin & The Affiliated Hospital of Hangzhou Normal University and Zhejiang University, Hangzhou, China.
Department of Surgery, Oregon Health and Science University, Portland, OR, USA.

Li-Min Lun (LM)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China.

Qing-Wu Tian (QW)

Department of Clinical Laboratory, The Affiliated Hospital of Qingdao University, Qingdao, China. tainqw@126.com.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH